Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1375-1378
Published online before print May 1, 2008, doi: 10.1161/ATVBAHA.108.166629
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/7/1375    most recent
ATVBAHA.108.166629v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stampfuss, J.-J.
Right arrow Articles by Weber, A.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stampfuss, J.-J.
Right arrow Articles by Weber, A.-A.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1375.)
© 2008 American Heart Association, Inc.


Cell Biology and Signaling

Complete Downmodulation of P-Selectin Glycoprotein Ligand in Monocytes Undergoing Apoptosis

Jan-Julius Stampfuss; Petra Censarek; Jens W. Fischer; Gernot Kaber; Bernhard H. Rauch; Kerstin Freidel; Ute Fischer; Klaus Schulze-Osthoff; Tilo Grosser; Maria Grandoch; Karsten Schrör; Artur-Aron Weber

From the Institut für Pharmakologie und Klinische Pharmakologie (J.-J.S., P.C., J.W.F., G.K., B.H.R., K.F., K.S.), Universitätsklinikum Düsseldorf, Germany; the Institut für Molekulare Medizin (U.T., K.S.-O.), Universitätsklinikum Düsseldorf, Germany; the Institute for Translational Medicine and Therapeutics (T.G.), University of Pennsylvania School of Medicine, Philadelphia; and the Institut für Pharmakologie (M.G., A.-A.W.), Universität Duisburg-Essen, Universitätsklinikum Essen, Germany.

Correspondence to Artur-Aron Weber, MD, Institut für Pharmakologie, Universität Duisburg-Essen, Universitätsklinikum Essen, Hufelandstr. 55, D-45122 Essen, Germany. E-mail artur.weber{at}uk-essen.de

Objectives— Apoptotic monocytes release membrane microparticles which may play a major role in thrombogenicity through a P-selectin glycoprotein ligand (PGSL-1)–mediated mechanism. We have studied systematically the regulation of PSGL-1 expression and function in apoptotic monocytic cells.

Methods and Results— PSGL-1 expression (flow cytometry, immunofluorescence microscopy, immunoblot) was virtually abolished in apoptotic monocytes by proteolytic shedding. This was accompanied by a complete loss of PSGL-1–mediated platelet–leukocyte (flow cytometry) and leukocyte–endothelial cell (parallel plate flow chamber) interactions. Systematic screening of protease inhibitors combined with knock-out and siRNA experiments characterized the PSGL-1-cleaving enzyme as an N-ethylmaleimide-inhibitable metalloproteinase of the ADAM family.

Conclusions— Downmodulation of PGSL-1 in apoptotic monocytes may prevent ectopic cell clearance in the peripheral vasculature to reduce local inflammatory and proliferative responses. Depletion of PSGL-1 expression on apoptotic microparticles may also act as a molecular switch to modulate their thrombogenic activity.

We have studied P-selectin glycoprotein ligand (PSGL-1) expression and function in apoptotic monocytic cells. PSGL-1 expression was virtually abolished by proteolytic ectodomain shedding resulting in a complete loss of platelet–leukocyte and leukocyte–endothelial cell interactions. Downmodulation of PGSL-1 may prevent ectopic cell clearance and may act as a molecular switch to reduce thrombogenicity.


Key Words: PSGL-1 • apoptosis • monocytes • platelets • endothelial cells